Register entry

Slayback Pharma LLC

Data as of · How to read this entry

Registered sites
0
Active NDC listings
2
Live patents
0
Shortage listings
2
Countries
0
Alert

Drug shortage listings

2
DrugPresentationStatusAvailabilityPosted / updated
Dexmedetomidine Hydrochloride InjectionAnesthesiaDexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 71225-126-05)To Be Discontinued-5 Jun 20265 Jun 2026
Dexmedetomidine Hydrochloride InjectionAnesthesiaDexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 71225-126-06)To Be Discontinued-5 Jun 20265 Jun 2026
Catalogue

Drug listings by form and route

2

2 active NDC listings: 2 human prescription drug. By marketing category: ANDA 1, NDA 1.

Dosage formNDCs
injection1
suspension1
RouteNDCs
intravenous1
oral1
Labeller name on the listingNDCs
slayback pharma llc2
Catalogue

Marketed products

2
BrandGeneric nameForm / routeNDC
BACLOFENBACLOFENsuspension, oral71225-140ANDA
VIVIMUSTABENDAMUSTINE HYDROCHLORIDEinjection, intravenous71225-120NDA
Compare

Other companies listing baclofen

Enquiry

Common questions

Is Slayback Pharma LLC FDA approved?
Slayback Pharma LLC holds no registered establishment of its own; 2 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Slayback Pharma LLC make?
2 products are listed under Slayback Pharma LLC in the openFDA NDC Directory, most often as injection; suspension. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.